A Phase I, Single-center, Open-label, Single-dose Study to Evaluate the Effect of Food, Gender, and Age on the Pharmacokinetic Profile of Orally Administered SUVN-G3031 in Healthy Subjects

Trial Profile

A Phase I, Single-center, Open-label, Single-dose Study to Evaluate the Effect of Food, Gender, and Age on the Pharmacokinetic Profile of Orally Administered SUVN-G3031 in Healthy Subjects

Recruiting
Phase of Trial: Phase I

Latest Information Update: 04 Aug 2017

At a glance

  • Drugs SUVN G3031 (Primary)
  • Indications Cognition disorders
  • Focus Pharmacokinetics
  • Sponsors Suven Life Sciences
  • Most Recent Events

    • 29 Jul 2017 Planned End Date changed from 1 Jul 2017 to 1 Oct 2017.
    • 29 Jul 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Sep 2017.
    • 02 May 2017 Planned End Date changed from 1 May 2017 to 1 Jul 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top